These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 29130987)
1. Relationship between RAS Association Domain Family Protein 1A Promoter Methylation and the Clinicopathological Characteristics in Patients with Ovarian Cancer: A Systematic Meta-Analysis. Wang H; Cui M; Zhang S; He J; Song L; Chen Y Gynecol Obstet Invest; 2018; 83(4):349-357. PubMed ID: 29130987 [TBL] [Abstract][Full Text] [Related]
2. Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis. Shi H; Li Y; Wang X; Lu C; Yang L; Gu C; Xiong J; Huang Y; Wang S; Lu M PLoS One; 2013; 8(10):e76787. PubMed ID: 24116157 [TBL] [Abstract][Full Text] [Related]
3. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis. Si JG; Su YY; Han YH; Chen RH Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911 [TBL] [Abstract][Full Text] [Related]
4. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors]. Ma L; Zhang JH; Liu FR; Zhang X Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):657-9. PubMed ID: 16438885 [TBL] [Abstract][Full Text] [Related]
5. Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases. Zhu X; Yang H; Lang J; Zhang Y Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():103-108. PubMed ID: 31242460 [TBL] [Abstract][Full Text] [Related]
6. Association between RASSF1A promoter methylation and renal cell cancer susceptibility: a meta-analysis. Huang YQ; Guan H; Liu CH; Liu DC; Xu B; Jiang L; Lin ZX; Chen M Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173228 [TBL] [Abstract][Full Text] [Related]
7. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA. Giannopoulou L; Chebouti I; Pavlakis K; Kasimir-Bauer S; Lianidou ES Oncotarget; 2017 Mar; 8(13):21429-21443. PubMed ID: 28206954 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis. Chen C; Zhu Y; Zhang H; Xiao L Gynecol Obstet Invest; 2024; 89(5):363-375. PubMed ID: 38615670 [TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development. Bhagat R; Chadaga S; Premalata CS; Ramesh G; Ramesh C; Pallavi VR; Krishnamoorthy L Cell Oncol (Dordr); 2012 Dec; 35(6):473-9. PubMed ID: 23055343 [TBL] [Abstract][Full Text] [Related]
10. Association between Ras association domain family 1A promoter methylation and esophageal squamous cell carcinoma: a meta-analysis. Yang JZ; Ji AF; Wang JS; Chen ZY; Wen SW Asian Pac J Cancer Prev; 2014; 15(9):3921-5. PubMed ID: 24935575 [TBL] [Abstract][Full Text] [Related]
11. [Methylation status of RASSF1A and clinical efficacy of neoadjuvant therapy in patients with advanced epithelial ovarian cancer]. Xie G; Hu C; Huang M Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):631-3. PubMed ID: 21873787 [TBL] [Abstract][Full Text] [Related]
12. The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA). Niu H; Yang J; Yang K; Huang Y Medicine (Baltimore); 2017 Nov; 96(46):e8630. PubMed ID: 29145283 [TBL] [Abstract][Full Text] [Related]
13. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis. Shi DT; Han M; Gao N; Tian W; Chen W Tumour Biol; 2014 Feb; 35(2):943-8. PubMed ID: 23982879 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC). Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549 [TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer]. Wei H; Fang N; Guo L; Wu Z; Zhou Q Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870 [TBL] [Abstract][Full Text] [Related]
16. Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: Meta-analysis and TCGA analysis. Hu F; Chen L; Bi MY; Zheng L; He JX; Huang YZ; Zhang Y; Zhang XL; Guo Q; Luo Y; Tang WR; Sheng MM Pathol Res Pract; 2020 Aug; 216(8):153009. PubMed ID: 32703486 [TBL] [Abstract][Full Text] [Related]
17. Promoter Methylation of RASSF1A Gene in Egyptian Patients with Ovarian Cancer. Rezk NA; Mohamed RH; Alnemr AA; Harira M Appl Biochem Biotechnol; 2018 May; 185(1):153-162. PubMed ID: 29098560 [TBL] [Abstract][Full Text] [Related]
18. The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics. Shao C; Dai W; Li H; Tang W; Jia S; Wu X; Luo Y PLoS One; 2017; 12(2):e0171676. PubMed ID: 28207831 [TBL] [Abstract][Full Text] [Related]
19. Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis. Meng RW; Li YC; Chen X; Huang YX; Shi H; Du DD; Niu X; Lu C; Lu MX Sci Rep; 2016 Feb; 6():20756. PubMed ID: 26857374 [TBL] [Abstract][Full Text] [Related]
20. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis. Wen G; Wang H; Zhong Z Medicine (Baltimore); 2018 Mar; 97(11):e9971. PubMed ID: 29538221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]